Exabis Library
Welcome to the e-CCO Library!
P744: Therapeutic gain of continued, long-term infliximab therapy in Crohn’s disease patients with response but non-remission after one year of infliximab therapy
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P745 Perianal disease in Crohn’s disease is associated with higher rate of hospitalisation and mortality despite a higher utilisation of biologics: Report from the epiIIRN cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P745: Impact of migration on IBD incidence in 8 European populations: results from Epicom 2010 inception cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P745: Incidence of indeterminate colitis in the EPIMAD registry decreases over the period 1988–2014
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P745: Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P745: Switching between anti-TNF originator and biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P746 Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P746: Anthropometric measures in adolescents with inflammatory bowel disease: A population-based study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P746: Clinical characteristic of Crohn's disease patients in Polish population
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P746: Identification of Altered Microbial Genera at Baseline in Adalimumab Clinical Remitters and an Absence of Change in Total Microbial Composition Post Induction Treatment in the SERENE UC Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P746: Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P747 Adherence to ECCO guidelines for cancer surveillance is associated to the detection of early cancer: A retrospective, single-centre, cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P747: A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P747: Extracolonic and colonic cancer risk in patients with ulcerative colitis and primary sclerosing cholangitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P747: Predictors of thiopurine treatment failure in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P747: The impact of COVID-19 on patients with Inflammatory Bowel Disease: A population-based study using artificial intelligence.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P748 Characteristics of inflammatory bowel diseases in different stage of adolescence
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P748: Clinical outcomes and prognostic factors of methotrexate therapy in combination with anti-TNF agents in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P748: High stress and significant decrease in productivity in caregivers of IBD patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P748: Pharmacokinetics, relative bioavailability, and dose proportionality of a tablet formulation of the sphingosine 1-phosphate-1 receptor modulator VTX002 (formerly OPL-002)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM